— Know what they know.
Not Investment Advice

INLB OTC

Item 9 Labs Corp.
1W: -99.0% 1M: -99.0% 3M: -99.0% YTD: -99.0% 1Y: -99.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±4955.7%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $70181 mcap · 524M float · 0.0039% daily turnover

📊 Key Metrics

TTM
$20M
Revenue
-17.4% YoY
$-31M
Net Income
-42.7% YoY
$-3M
Free Cash Flow
+50.0% YoY
56.1%
Gross Margin
-59.1%
Op. Margin
-117.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-47.3%
ROA-26.7%
ROIC-18.4%

Valuation

P/E-0.0
P/B0.0
EV/EBITDA-2.0

Leverage

Debt/Equity0.65
Current Ratio0.06
Interest Cov.-2.3x

Quality Scores

Piotroski F2/9
Altman Z-1.97
Beneish M-3.37

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms